MAYZENT Trademark

Trademark Overview


On Friday, September 12, 2014, a trademark application was filed for MAYZENT with the United States Patent and Trademark Office. The USPTO has given the MAYZENT trademark a serial number of 79156316. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 26, 2021. This trademark is owned by Novartis AG. The MAYZENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
mayzent

General Information


Serial Number79156316
Word MarkMAYZENT
Filing DateFriday, September 12, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 26, 2021
Registration Number4714545
Registration DateTuesday, April 7, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
Pseudo MarkMAY ZENT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, May 16, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 20, 2023GENERIC MADRID TRANSACTION SENT TO IB
Monday, March 20, 2023INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, March 20, 2023GENERIC MADRID TRANSACTION CREATED
Tuesday, July 26, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 26, 2021CANCELLED SECTION 71
Thursday, October 19, 2017INTERNATIONAL REGISTRATION RENEWED
Friday, June 26, 2015NOTIFICATION PROCESSED BY IB
Wednesday, June 10, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 10, 2015FINAL DISPOSITION PROCESSED
Thursday, May 7, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 7, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, January 20, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 31, 2014NOTICE OF PUBLICATION
Tuesday, December 16, 2014APPLICATION FILING RECEIPT MAILED
Thursday, December 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Wednesday, December 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 9, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 4, 2014SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB